Europe Grants DefenAge Skincare Master Patent for Its Core Technology

September 3, 2019

Progenitor Biologics, LLC, the manufacturer and distributor of the revolutionary, evidence-based, anti-aging skincare products, DefenAge Skincare, is proud to announce that the European Patent Office has granted DefenAge’s master patent that covers DefenAge’s core technology. The patent is entitled “Stem Cell Stimulating Compositions,” patent number: EP 3157504.
The patent protects the exclusive rights of DefenAge to use the spectrum of immune peptides called defensins in topical cosmetic formulations in a specific range of concentrations effective to provide an anti-aging effect on a global scale, specifically to substantially reduce the appearance of wrinkles, pore size, brown and age spots, and redness; to address uneven skin tone and surface imperfections; to improve skin’s brightness, radiance, evenness and clarity; to normalize skin’s oiliness and hydration; and to correct skin firmness, sagging contours, lines and irregularities in texture.
Read more at PR Newswire >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • BTL Establishes New Laser Division and Introduces Exolase One
    • SkinMedica Launches Barrier Calming Cream
    • CEDR HR Solutions Supports AmSpa Members as Platinum Vendor Affiliate
    • Galderma Opens New U.S. and Latin America Headquarters in Miami
    • Raging Agency Becomes Silver Vendor Affiliate with the American Med Spa Association